Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
A review identified 15 reports of Wernicke encephalopathy among patients receiving GLP-1 therapies, most accompanied by poor intake, vomiting, weight loss, or malnutrition, highlighting a rare safety signal without establishing drug-related causality.
Emergency Medicine October 22nd 2026
Medical Xpress
Five years after participation in randomized trials, children with fetal alcohol spectrum disorder who received choline supplementation during early childhood demonstrated higher nonverbal IQ and working-memory performance than peers who received placebo, suggesting the intervention may influence long-term neurodevelopmental trajectories.
Child & Adolescent Psychiatry October 19th 2026
Childhood Obesity
Nearly one in six pediatric GLP-1 receptor agonist users received a nutritional-deficiency or related diagnosis within one year, while nutrition counseling remained limited and generally occurred months after treatment initiation.
Adolescent Medicine October 8th 2026
Medical News Today (MNT)
Experts reviewing available evidence suggest melatonin and magnesium may support sleep through different mechanisms, though benefits appear dependent on the underlying cause of sleep disturbance and overall evidence remains mixed, particularly for magnesium.
Behavioral Health October 1st 2026
European Heart Journal
Targeted vitamin D supplementation successfully addressed widespread vitamin D insufficiency among post-myocardial infarction patients but did not significantly reduce major adverse cardiovascular events during more than four years of follow-up.
Cardiology September 30th 2026
Cureus
A 25-year-old man with approximately three years of daily high-volume energy drink consumption developed mixed-pattern liver injury with cholestatic histology. Exposure cessation coincided with substantial biochemical improvement, although causality remained uncertain and alternative explanations were not fully excluded.
Hepatology September 1st 2026